FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Apotex Brimonidine Tartrate/Timolol Maleate Recall

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0

Apotex Corp. · Weston, FL

Risk level
Class II
Reported by FDA
Mar 25, 2026
Recall ID
D-0407-2026
Check your lot numberHow we source this data

Summary

Apotex recalled Brimonidine Tartrate/Timolol Maleate starting Mar 5, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0407-2026 on Mar 25, 2026. Reason: Lack of Assurance of Sterility. Status: Ongoing.

Why it was recalled

Lack of Assurance of Sterility

Product description

Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1.

Lot numbers, UPCs & expiration codes

Lots VJ8599, Exp Date 09/30/2026 & VL1668, Exp Date 01/31/2027

Where it was sold

U.S. Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0407-2026
Classification
Class II
Status
Ongoing
Recall initiated
Mar 5, 2026
FDA report date
Mar 25, 2026
Quantity
107,136 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Corp.

Original FDA data

Every field from FDA enforcement report D-0407-2026, exactly as published.

Show all FDA fields
City
Weston
State
FL
Status
Ongoing
Country
United States
Event ID
98536
Address
2400 N Commerce Pkwy Ste 400
Code information
Lots VJ8599, Exp Date 09/30/2026 & VL1668, Exp Date 01/31/2027
Postal code
33326-3253
Report date
Mar 25, 2026
Product type
Drugs
Recall number
D-0407-2026
Classification
Class II
Recalling firm
Apotex Corp.
Product quantity
107,136 vials
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1.
Distribution pattern
U.S. Nationwide
Recall initiation date
Mar 5, 2026
Initial firm notification
Letter
Center classification date
Mar 27, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0407-2026, published Mar 25, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls